These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [The clinical research of serum soluble CD40L and high sensitivie C-reactive protein in patients with acute coronary syndrome]. Fu HJ; Yuan M; Ren LF; Guo WY Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):180-1. PubMed ID: 21315051 [TBL] [Abstract][Full Text] [Related]
47. Gender-specific differences in biomarkers responses to acute coronary syndromes and revascularization procedures. Sbarouni E; Georgiadou P; Voudris V Biomarkers; 2011 Sep; 16(6):457-65. PubMed ID: 21851313 [TBL] [Abstract][Full Text] [Related]
48. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Möckel M; Danne O; Müller R; Vollert JO; Müller C; Lueders C; Störk T; Frei U; Koenig W; Dietz R; Jaffe AS Clin Chim Acta; 2008 Jul; 393(2):103-9. PubMed ID: 18423399 [TBL] [Abstract][Full Text] [Related]
49. [Correlation between acute coronary syndrome, hyperlipoproteinemia and statins]. Panić G; Petrović M; Jovelic A; Dejanović J; Cemerlić-Adić N; Panić M Med Pregl; 2009; 62 Suppl 3():33-6. PubMed ID: 19702113 [TBL] [Abstract][Full Text] [Related]
50. Matrix metalloproteinases in acute coronary syndromes: a new therapeutic target? Celik T; Iyisoy A; Kardesoglu E; Bugan B; Isik E Int J Cardiol; 2009 May; 134(3):402-4. PubMed ID: 18237788 [TBL] [Abstract][Full Text] [Related]
51. Early statin therapy in elderly patients presenting with acute coronary syndrome causing less heart failure. Saab FA; Petrina M; Kline-Rogers E; Fang J; Otten R; Mukherjee D; Eagle KA Indian Heart J; 2006; 58(4):321-4. PubMed ID: 19039148 [TBL] [Abstract][Full Text] [Related]
52. Statins in acute coronary syndromes: do the guideline recommendations match the evidence? Morrissey RP; Diamond GA; Kaul S J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735 [TBL] [Abstract][Full Text] [Related]
54. Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome. Rosenson RS; Brewer HB; Rader DJ Circ Res; 2014 Jun; 114(12):1880-9. PubMed ID: 24902972 [TBL] [Abstract][Full Text] [Related]
55. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome. Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516 [TBL] [Abstract][Full Text] [Related]
56. Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Corson MA; Jones PH; Davidson MH Am J Cardiol; 2008 Jun; 101(12A):41F-50F. PubMed ID: 18549871 [TBL] [Abstract][Full Text] [Related]
57. [The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acute coronary syndrome]. Shal'nev VI Klin Med (Mosk); 2007; 85(11):46-50. PubMed ID: 18219956 [TBL] [Abstract][Full Text] [Related]
58. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study. Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920 [TBL] [Abstract][Full Text] [Related]
59. Statins for the treatment of antiphospholipid syndrome? Jajoria P; Murthy V; Papalardo E; Romay-Penabad Z; Gleason C; Pierangeli SS Ann N Y Acad Sci; 2009 Sep; 1173():736-45. PubMed ID: 19758223 [TBL] [Abstract][Full Text] [Related]